Responses to parliamentary questions
Question from Deputy John Connolly - PQ 65372-25
Deputy Connolly asked about the inclusion of selpercatinib (also pralsetinib) on the drug reimbursement scheme. Read the HSE response.
From: Communications and public affairs
Published: November 2025
Updated: December 2025
Documents
Summary
To ask the Minister for Health for an update on the consideration within her Department towards the inclusion of selpercatinib (also pralsetinib) on the drug reimbursement scheme; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it